- Home
- MHH vs ACRV Comparison
MHH vs ACRV Comparison
Compare MHH & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHH
- ACRV
- Stock Information
- Founded
- MHH 1986
- ACRV 2018
- Country
- MHH United States
- ACRV United States
- Employees
- MHH N/A
- ACRV N/A
- Industry
- MHH Professional Services
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- MHH Consumer Discretionary
- ACRV Health Care
- Exchange
- MHH Nasdaq
- ACRV Nasdaq
- Market Cap
- MHH 81.5M
- ACRV 74.5M
- IPO Year
- MHH N/A
- ACRV 2022
- Fundamental
- Price
- MHH $8.14
- ACRV $2.38
- Analyst Decision
- MHH
- ACRV Buy
- Analyst Count
- MHH 0
- ACRV 5
- Target Price
- MHH N/A
- ACRV $14.67
- AVG Volume (30 Days)
- MHH 26.7K
- ACRV 1.3M
- Earning Date
- MHH 11-12-2025
- ACRV 11-13-2025
- Dividend Yield
- MHH N/A
- ACRV N/A
- EPS Growth
- MHH N/A
- ACRV N/A
- EPS
- MHH N/A
- ACRV N/A
- Revenue
- MHH $196,657,000.00
- ACRV N/A
- Revenue This Year
- MHH N/A
- ACRV N/A
- Revenue Next Year
- MHH $3.78
- ACRV $805.34
- P/E Ratio
- MHH N/A
- ACRV N/A
- Revenue Growth
- MHH 1.24
- ACRV N/A
- 52 Week Low
- MHH $6.20
- ACRV $1.05
- 52 Week High
- MHH $16.00
- ACRV $8.00
- Technical
- Relative Strength Index (RSI)
- MHH 66.41
- ACRV 58.82
- Support Level
- MHH $7.32
- ACRV $2.22
- Resistance Level
- MHH $8.00
- ACRV $2.39
- Average True Range (ATR)
- MHH 0.65
- ACRV 0.18
- MACD
- MHH 0.10
- ACRV 0.00
- Stochastic Oscillator
- MHH 76.36
- ACRV 79.17
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.